{"filing":{"accession_number":"0001213900-26-080991","cik":"0000839087","ticker":"VASO","company_name":"VASO Corp","form":"8-K","filing_date":"2026-07-23","report_date":null,"primary_document":"ea0299047-8k_vaso.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/839087/000121390026080991/ea0299047-8k_vaso.htm"},"events":[{"id":20194,"run_id":18179,"accession_number":"0001213900-26-080991","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Shaun McMeans was appointed as a Class III director of VASO Corporation effective July 23, 2026. The disclosure emphasizes his substantial public company finance and accounting experience, including prior service as CFO of HTG Molecular Diagnostics (2012–2023), and his appointment to the audit committee as a financial expert. Director appointments are material governance events affecting the composition and expertise of the board.","company_name":"VASO Corp","ticker":"VASO","filing_date":"2026-07-23","form":"8-K","submitted_at":null,"items":[{"id":19494,"accession_number":"0001213900-26-080991","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Shaun McMeans was appointed as a Class III director of VASO Corporation effective July 23, 2026. The disclosure emphasizes his substantial public company finance and accounting experience, including prior service as CFO of HTG Molecular Diagnostics (2012–2023), and his appointment to the audit committee as a financial expert. Director appointments are material governance events affecting the composition and expertise of the board.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T21:15:40.997079+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19494,"accession_number":"0001213900-26-080991","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Shaun McMeans was appointed as a Class III director of VASO Corporation effective July 23, 2026. The disclosure emphasizes his substantial public company finance and accounting experience, including prior service as CFO of HTG Molecular Diagnostics (2012–2023), and his appointment to the audit committee as a financial expert. Director appointments are material governance events affecting the composition and expertise of the board.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-23T21:15:40.997079+00:00","company_name":"VASO Corp","ticker":"VASO","filing_date":"2026-07-23"}]}